Circular RNAs in human cancer. Issue 1 (December 2017)

• Record Type: Journal Article
• Authors: Wang, Yumin; Mo, Yongzhen; Gong, Zhaojian; Yang, Xiang; Yang, Mo; Zhang, Shanshan; Xiong, Fang; Xiang, Bo; Zhou, Ming; Liao, Qianjin; Zhang, Wenling; Li, Xiayu; Li, Xiaoling; Li, Yong; Li, Guiyuan; Zeng, Zhaoyang; Xiong, Wei
• Is Part Of: Molecular cancer. Volume 16:Issue 1(2017)
• Page Start: 1
• Page End: 8
• Publication Date: 2017-12
• Subjects: Circular RNAs -- Cancer -- Splicing -- Biomarker -- Regulation; Cancer -- Molecular aspects -- Periodicals; 616.994
• DOI: 10.1186/s12943-017-0598-7
• Languages: English
• ISSNs: 1476-4598

Abstract

Abstract CircRNAs are a novel type of RNAs. With the newly developed technology of next-generation sequencing (NGS), especially RNA-seq technology, over 30, 000 circRNAs have already been found. Owing to their unique structure, they are more stable than linear RNAs. CircRNAs play important roles in the carcinogenesis of cancer. The expression of circRNAs is correlated with patients' clinical characteristics, and circRNAs play a vital role in many aspects of malignant phenotypes, including cell cycle, apoptosis, vascularization, and invasion; metastasis as a RNA sponge, binding to RBP; or translation. Therefore, it is meaningful to further study the mechanism of interactions between circRNAs and tumors. The role of circRNAs as molecular markers or potential targets will provide promising application perspectives, such as early tumor diagnosis, therapeutic evaluation, prognosis prediction, and even gene therapy for tumors.